Conferences

RSS

DuPont Merck reports pharmacokinetic data for novel gpIIb/IIIa antagonist

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Glaxo Wellcome evaluates new alpha1a-adrenoceptor antagonist

Dec. 13, 1996

Treatment options for photodamaged skin

Dec. 3, 1996

Aquaphore ointment protects premature infants from dermatological infections

Dec. 3, 1996

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

New anxiolytic under development at Parke-Davis

Dec. 2, 1996

Antiepileptic agent reported by Parke-Davis

Dec. 2, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996